Study identifier:NIS-MENA-SA-IRS-2010/01
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Epidemiological study to describe NSCLC clinical management patterns in MENA. Lung-EPICLIN/ KSA
NSCLC patient characteristics
-
No
-
All
54
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2012 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|